Skip to Content

Nevanac Approval History

FDA Approved: Yes (First approved August 19, 2005)
Brand name: Nevanac
Generic name: nepafenac
Dosage form: Ophthalmic Suspension
Company: Alcon, Inc.
Treatment for: Postoperative Ocular Inflammation

Nevanac (nepafenac) is a topical nonsteroidal anti-inflammatory (NSAID) and analgesic prodrug indicated for the treatment of pain and inflammation associated with cataract surgery.

Development History and FDA Approval Process for Nevanac

DateArticle
Aug 19, 2005Approval Nevanac Alcon, Inc. - Treatment for Pain and Inflammation Associated with Cataract Surgery

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide